Lipocine Inc. — Director's Dealing 2017

Dec 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2017-12-06

Reporting Person: Bass Gregory Brooks (EVP and Chief Commercial Offic)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-06	Stock Options (Right to Buy)	$3.52	A	75000	Acquired	2027-12-06	Common Stock (75000)	Direct

Footnotes

F1: Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 6, 2018, while the remaining 2/3 of the shares subject to the award have vesting monthly on a prorata basis over the following two years.